Bioventus stockholders approve board declassification, annual director elections by 2026

Bioventus Inc.

Declassification Charter Amendment approved: 61,439,110 for, 135,200 against, 22,572 abstain.
Board will shift to annual elections; entire board elected yearly starting 2026 annual meeting.
Class III directors elected: Robert E. Claypoole, Philip G. Cowdy, Martin P. Sutter.
Ratification of Grant Thornton as auditor for FY 2024: 71,179,096 for, 14,660 against.
Amendment effective upon filing certificate of amendment with Delaware Secretary of State.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.